BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. Elife 2021;10:e69302. [PMID: 34569939 DOI: 10.7554/eLife.69302] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Noël F, Mauroy B. Propagation of an idealized infection in an airway tree, consequences of the inflammation on the oxygen transfer to blood. J Theor Biol 2023;561:111405. [PMID: 36639022 DOI: 10.1016/j.jtbi.2023.111405] [Reference Citation Analysis]
2 Notsu K, El Daous H, Mitoma S, Wu X, Norimine J, Sekiguchi S. Identifying Pathogen and Allele Type Simultaneously in a Single Well Using Droplet Digital PCR. mSphere 2023;:e0049322. [PMID: 36625728 DOI: 10.1128/msphere.00493-22] [Reference Citation Analysis]
3 Song H, Yuan Z, Liu S, Jin Z, Sun G. Mathematical modeling the dynamics of SARS-CoV-2 infection with antibody-dependent enhancement. Nonlinear Dyn 2023;111:2943-58. [PMID: 36246668 DOI: 10.1007/s11071-022-07939-w] [Reference Citation Analysis]
4 Martin-Blondel G, Marcelin AG, Soulié C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, Dorival C, Nailler L, Boston A, Ronchetti AM, Melenotte C, Cabié A, Choquet C, Trinh-Duc A, Lacombe K, Gaube G, Coustillères F, Pourcher V, Martellosio JP, Peiffer-Smadja N, Chauveau M, Housset P, Piroth L, Devaux M, Pialoux G, Martin A, Dubee V, Frey J, Le Bot A, Cazanave C, Petua P, Liblau R, Carrat F, Yordanov Y. Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir. Clin Microbiol Infect 2022:S1198-743X(22)00640-1. [PMID: 36586513 DOI: 10.1016/j.cmi.2022.12.016] [Reference Citation Analysis]
5 Korosec CS, Farhang-Sardroodi S, Dick DW, Gholami S, Ghaemi MS, Moyles IR, Craig M, Ooi HK, Heffernan JM. Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex. Sci Rep 2022;12:21232. [PMID: 36481777 DOI: 10.1038/s41598-022-25134-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol 2022;:1-15. [PMID: 36460930 DOI: 10.1038/s41579-022-00822-w] [Reference Citation Analysis]
7 Mastrorosa I, Cozzi-Lepri A, Colavita F, Lalle E, Mazzotta V, Cimaglia C, Paulicelli J, Matusali G, Fabeni L, Carletti F, Rosati S, Vita S, Giannico G, Piselli P, Biliotti E, Moghazi SA, Mosti S, Girardi E, Nicastri E, Garbuglia AR, Maggi F, Vaia F, Antinori A. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis. J Clin Virol 2022;157:105299. [PMID: 36183546 DOI: 10.1016/j.jcv.2022.105299] [Reference Citation Analysis]
8 Cevik M, Kalil AC. Omicron variant: assessing the duration of viral shedding and its implications. Clin Microbiol Infect 2022:S1198-743X(22)00591-2. [PMID: 36442799 DOI: 10.1016/j.cmi.2022.11.019] [Reference Citation Analysis]
9 Whitaker M, Elliott J, Bodinier B, Barclay W, Ward H, Cooke G, Donnelly CA, Chadeau-Hyam M, Elliott P. Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England. Nat Commun 2022;13:6856. [PMID: 36369151 DOI: 10.1038/s41467-022-34244-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Meurisse M, Van Oyen H, Blot K, Catteau L, Serrien B, Klamer S, Cauët E, Robert A, Van Goethem N. Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data. BMC Infect Dis 2022;22:839. [DOI: 10.1186/s12879-022-07777-6] [Reference Citation Analysis]
11 Whitfield CA, Hall I. Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential. Journal of Theoretical Biology 2022. [DOI: 10.1016/j.jtbi.2022.111335] [Reference Citation Analysis]
12 Yang J, Liu MQ, Liu L, Li X, Xu M, Lin H, Liu S, Hu Y, Li B, Liu B, Li M, Sun Y, Chen YQ, Shi ZL, Yan H. A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern. Cell Mol Immunol 2022;19:1279-89. [PMID: 36220993 DOI: 10.1038/s41423-022-00929-3] [Reference Citation Analysis]
13 Granerud BK, Ueland T, Lind A, Søraas A, Fevang B, Steffensen AK, Al-Baldawi H, Lund-Johansen F, Aukrust P, Halvorsen B, Dahl TB, Dudman S, Müller F, Holter JC. Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2. Viruses 2022;14. [PMID: 36366518 DOI: 10.3390/v14112420] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Oksanen LAH, Virtanen J, Sanmark E, Rantanen N, Venkat V, Sofieva S, Aaltonen K, Kivistö I, Svirskaite J, Pérez AD, Kuula J, Levanov L, Hyvärinen AP, Maunula L, Atanasova NS, Laitinen S, Anttila VJ, Lehtonen L, Lappalainen M, Geneid A, Sironen T. SARS-CoV-2 indoor environment contamination with epidemiological and experimental investigations. Indoor Air 2022;32:e13118. [PMID: 36305066 DOI: 10.1111/ina.13118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Dings C, Meiser P, Holzer F, Flegel M, Selzer D, Nagy E, Mösges R, Klussmann JP, Lehr T. Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients. Pharmaceutics 2022;14:2059. [DOI: 10.3390/pharmaceutics14102059] [Reference Citation Analysis]
16 Notsu K, El Daous H, Mitoma S, Wu X, Norimine J, Sekiguchi S. Identifying Pathogen and Allele Type Simultaneously (IPATS) in a single well using droplet digital PCR.. [DOI: 10.1101/2022.09.10.507438] [Reference Citation Analysis]
17 Ergoren MC, Komurcu K, Tuncel G, Akan G, Ozverel CS, Dalkan C, Kalayci M, Sanlıdag T. Impact of SARS-CoV-2 Delta and Omicron variants on viral burden and cycle threshold in BNT162b2-vaccinated 12-18 years group. Braz J Microbiol 2022. [PMID: 36050578 DOI: 10.1007/s42770-022-00820-3] [Reference Citation Analysis]
18 Lee KS, Wong TY, Russ BP, Horspool AM, Miller OA, Rader NA, Givi JP, Winters MT, Wong ZYA, Cyphert HA, Denvir J, Stoilov P, Barbier M, Roan NR, Amin MS, Martinez I, Bevere JR, Damron FH. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice. PLoS One 2022;17:e0273430. [PMID: 36037222 DOI: 10.1371/journal.pone.0273430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Barajas JG, Herrera-nolasco CI, Herrera-valdez MA, López SI. A probabilistic approach for the study of epidemiological dynamics of infectious diseases: basic model and properties.. [DOI: 10.1101/2022.08.16.22278844] [Reference Citation Analysis]
20 Garnett L, Tse C, Funk D, Dust K, Tran KN, Hedley A, Poliquin G, Bullard J, Strong JE. Differential Infectivity of Original and Delta Variants of SARS-CoV-2 in Children Compared to Adults. Microbiol Spectr 2022;:e0039522. [PMID: 35972128 DOI: 10.1128/spectrum.00395-22] [Reference Citation Analysis]
21 Klussmann J, Grosheva M, Meiser P, Lehmann C, Nagy E, Szijártó V, Nagy G, Konrat R, Flegel M, Holzer F, Groß D, Steinmetz C, Scherer B, Gruell H, Schlotz M, Klein F, de Aragão PA, Morr H, Saleh HA, Bilstein A, Russo B, Müller-scholtz S, Acikel C, Sahin H, Werkhäuser N, Allekotte S, Mösges R. COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN) Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients – results from a randomized, double-blind, placebo-controlled phase II clinical trial.. [DOI: 10.21203/rs.3.rs-1893502/v1] [Reference Citation Analysis]
22 Ait Mahiout L, Bessonov N, Kazmierczak B, Volpert V. Mathematical modeling of respiratory viral infection and applications to SARS‐CoV‐2 progression. Math Methods in App Sciences. [DOI: 10.1002/mma.8606] [Reference Citation Analysis]
23 Karron RA, Hetrich MK, Na YB, Knoll MD, Schappell E, Meece J, Hanson E, Tong S, Lee JS, Veguilla V, Dawood FS; SEARCH Study Team. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members. JAMA Netw Open 2022;5:e2227348. [PMID: 36044218 DOI: 10.1001/jamanetworkopen.2022.27348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 da Silva VH, Goes CP, Trevisoli PA, Lello R, Clemente LG, de Almeida TB, Petrini J, Coutinho LL. Simulation of group testing scenarios can boost COVID-19 screening power. Sci Rep 2022;12:11854. [PMID: 35831373 DOI: 10.1038/s41598-022-14626-8] [Reference Citation Analysis]
25 Hitchings MDT, Ranzani OT, Lind ML, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, de Moura Villela EF, Scaramuzzini Torres MS, de Oliveira SB, Schulz W, Almiron M, Said R, de Oliveira RD, Vieira da Silva P, de Araújo WN, Gorinchteyn JC, Dean NE, Andrews JR, Cummings DAT, Ko AI, Croda J. Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study. BMJ 2022;377:e070102. [PMID: 35697361 DOI: 10.1136/bmj-2022-070102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sun K, Tempia S, Kleynhans J, von Gottberg A, McMorrow ML, Wolter N, Bhiman JN, Moyes J, du Plessis M, Carrim M, Buys A, Martinson NA, Kahn K, Tollman S, Lebina L, Wafawanaka F, du Toit JD, Gómez-Olivé FX, Mkhencele T, Viboud C, Cohen C. SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron's impact in South African population cohorts. Sci Transl Med 2022;:eabo7081. [PMID: 35638937 DOI: 10.1126/scitranslmed.abo7081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
27 Whitaker M, Elliott J, Bodinier B, Barclay W, Ward H, Cooke G, Donnelly CA, Chadeau-hyam M, Elliott P. Variant-specific symptoms of COVID-19 among 1,542,510 people in England.. [DOI: 10.1101/2022.05.21.22275368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
28 Panatto D, Orsi A, Bruzzone B, Ricucci V, Fedele G, Reiner G, Giarratana N, Domnich A, Icardi G; STX Study Group. Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study. Viruses 2022;14:1033. [DOI: 10.3390/v14051033] [Reference Citation Analysis]
29 Covantes-rosales CE, Barajas-carrillo VW, Girón-pérez DA, Toledo-ibarra GA, Díaz-reséndiz KJG, Navidad-murrieta MS, Ventura-ramón GH, Pulido-muñoz ME, Mercado-salgado U, Ojeda-durán AJ, Argüero-fonseca A, Girón-pérez MI. Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City. IJERPH 2022;19:5719. [DOI: 10.3390/ijerph19095719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mahiout LA, Mozokhina A, Tokarev A, Volpert V. Virus replication and competition in a cell culture: Application to the SARS-CoV-2 variants. Applied Mathematics Letters 2022. [DOI: 10.1016/j.aml.2022.108217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Carruthers J, Xu J, Finnie T, Hall I. A within-host model of SARS-CoV-2 infection.. [DOI: 10.1101/2022.04.22.22274137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Trunfio M, Richiardi L, Alladio F, Staffilano E, Longo B, Venuti F, Ghisetti V, Burdino E, Bonora S, Vineis P, Di Perri G, Calcagno A. Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. Front Microbiol 2022;13:829393. [PMID: 35432272 DOI: 10.3389/fmicb.2022.829393] [Reference Citation Analysis]
33 Lam JH, Shivhare D, Chia TW, Chew SL, Sinsinbar G, Aw TY, Wong S, Venkatraman S, Lim FWI, Vandepapeliere P, Nallani M. Next-generation intranasal Covid-19 vaccine: a polymersome-based protein subunit formulation that provides robust protection against multiple variants of concern and early reduction in viral load of the upper airway in the golden Syrian hamster model.. [DOI: 10.1101/2022.02.12.480188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Sun K, Tempia S, Kleynhans J, Gottberg AV, Mcmorrow ML, Wolter N, Bhiman JN, Moyes J, Plessis MD, Carrim M, Buys A, Martinson NA, Kahn K, Tollman S, Lebina L, Wafawanaka F, du Toit JD, Gómez-olivé FX, Mkhencele T, Viboud C, Cohen C, the PHIRST group. Persistence of SARS-CoV-2 immunity, Omicron’s footprints, and projections of epidemic resurgences in South African population cohorts.. [DOI: 10.1101/2022.02.11.22270854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
35 Martínez-Baz I, Trobajo-Sanmartín C, Burgui C, Casado I, Castilla J. Transmission of SARS-CoV-2 infection and risk factors in a cohort of close contacts. Postgrad Med 2022. [PMID: 35102793 DOI: 10.1080/00325481.2022.2037360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lee KS, Wong TY, Russ BP, Horspool AM, Miller OA, Rader NA, Givi JP, Winters MT, Wong ZY, Cyphert HA, Denvir J, Stoilov P, Barbier M, Roan NR, Amin MS, Martinez I, Bevere JR, Damron FH. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice.. [DOI: 10.1101/2022.01.18.476863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Pitak-Arnnop P, Sirintawat N, Tangmanee C, Sukphopetch P, Meningaud JP, Neff A. Inanimate surface contamination of SARS-CoV-2 during midfacial fracture repair in asymptomatic COVID-19 patients. J Stomatol Oral Maxillofac Surg 2022:S2468-7855(22)00023-4. [PMID: 35063683 DOI: 10.1016/j.jormas.2022.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
38 Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM, Connolly S, Anderson DJ, Khullar G, Mackay M, Patel M, Kelly S, Manhertz A, Eiter I, Salgado D, Baker T, Howard B, Dudley JT, Mason CE, Nair M, Huang Y, Difiori J, Ho DD, Grubaugh ND, Grad YH. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study.. [DOI: 10.1101/2022.01.13.22269257] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 48.0] [Reference Citation Analysis]
39 Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A, Bausch FJ, Kaiser L, Vetter P, Eckerle I, Meyer B. Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron.. [DOI: 10.1101/2022.01.10.22269010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 44.0] [Reference Citation Analysis]
40 Kissler SM, Fauver JR, Mack C, Tai CG, Breban MI, Watkins AE, Samant RM, Anderson DJ, Metti J, Khullar G, Baits R, MacKay M, Salgado D, Baker T, Dudley JT, Mason CE, Ho DD, Grubaugh ND, Grad YH. Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons. N Engl J Med 2021;385:2489-91. [PMID: 34941024 DOI: 10.1056/NEJMc2102507] [Cited by in Crossref: 89] [Cited by in F6Publishing: 97] [Article Influence: 44.5] [Reference Citation Analysis]
41 Ke R, Zitzmann C, Ho DD, Ribeiro RM, Perelson AS. In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness. Proc Natl Acad Sci U S A 2021;118. [PMID: 34857628 DOI: 10.1073/pnas.2111477118] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 26.0] [Reference Citation Analysis]
42 Kidd SP, Burns D, Armson B, Beggs AD, Howson ELA, Williams A, Snell G, Wise EL, Goring A, Vincent-mistiaen Z, Grippon S, Sawyer J, Cassar C, Cross D, Lewis T, Reid SM, Rivers S, James J, Skinner P, Banyard A, Davies K, Ptasinska A, Whalley C, Ferguson J, Bryer C, Poxon C, Bosworth A, Kidd M, Richter A, Burton J, Love H, Fouch S, Tillyer C, Sowood A, Patrick H, Moore N, Andreou M, Morant N, Houghton R, Parker J, Slater-jefferies J, Brown I, Gretton C, Deans Z, Porter D, Cortes NJ, Douglas A, Hill SL, Godfrey KM, Fowler VL. RT-LAMP has high accuracy for detecting SARS-CoV-2 in saliva and naso/oropharyngeal swabs from asymptomatic and symptomatic individuals.. [DOI: 10.1101/2021.06.28.21259398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]